Ashleigh R. Tuite

6.4k total citations
124 papers, 3.3k citations indexed

About

Ashleigh R. Tuite is a scholar working on Modeling and Simulation, Infectious Diseases and Epidemiology. According to data from OpenAlex, Ashleigh R. Tuite has authored 124 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Modeling and Simulation, 50 papers in Infectious Diseases and 49 papers in Epidemiology. Recurrent topics in Ashleigh R. Tuite's work include COVID-19 epidemiological studies (52 papers), SARS-CoV-2 and COVID-19 Research (23 papers) and Influenza Virus Research Studies (23 papers). Ashleigh R. Tuite is often cited by papers focused on COVID-19 epidemiological studies (52 papers), SARS-CoV-2 and COVID-19 Research (23 papers) and Influenza Virus Research Studies (23 papers). Ashleigh R. Tuite collaborates with scholars based in Canada, United States and United Kingdom. Ashleigh R. Tuite's co-authors include David N. Fisman, Amy L. Greer, Isaac I. Bogoch, Joseph H. Tien, Marisa C. Eisenberg, Philippe Gros, Edwin Khoo, Alaka Mullick, David J. D. Earn and Junling Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Ashleigh R. Tuite

114 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashleigh R. Tuite Canada	29	1.3k	1.2k	990	498	291	124	3.3k
Nicholas C. Grassly United Kingdom	42	857 0.6×	2.8k 2.4×	1.3k 1.3×	625 1.3×	419 1.4×	124	5.6k
Joël Mossong Luxembourg	31	1.9k 1.4×	1.7k 1.4×	2.1k 2.1×	468 0.9×	149 0.5×	84	4.8k
Antonino Bella Italy	40	685 0.5×	1.5k 1.3×	1.9k 1.9×	568 1.1×	179 0.6×	196	4.8k
M. Elizabeth Halloran United States	27	874 0.7×	1.1k 0.9×	1.2k 1.2×	515 1.0×	99 0.3×	75	3.1k
Marco Massari Italy	21	1.5k 1.1×	823 0.7×	1.6k 1.6×	348 0.7×	352 1.2×	43	3.2k
Stefan Flasche United Kingdom	32	1.3k 1.0×	1.2k 1.1×	1.7k 1.7×	559 1.1×	239 0.8×	102	3.5k
James S. Koopman United States	37	978 0.7×	2.0k 1.8×	2.0k 2.1×	782 1.6×	135 0.5×	92	5.0k
Hitoshi Oshitani Japan	37	687 0.5×	1.9k 1.6×	2.0k 2.0×	362 0.7×	77 0.3×	179	4.5k
Joseph A. Lewnard United States	26	695 0.5×	1.4k 1.2×	833 0.8×	225 0.5×	164 0.6×	74	2.6k
Benjamin J. Silk United States	27	488 0.4×	1.7k 1.4×	882 0.9×	222 0.4×	96 0.3×	78	4.1k

Countries citing papers authored by Ashleigh R. Tuite

Since Specialization

Citations

This map shows the geographic impact of Ashleigh R. Tuite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashleigh R. Tuite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashleigh R. Tuite more than expected).

Fields of papers citing papers by Ashleigh R. Tuite

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashleigh R. Tuite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashleigh R. Tuite. The network helps show where Ashleigh R. Tuite may publish in the future.

Co-authorship network of co-authors of Ashleigh R. Tuite

This figure shows the co-authorship network connecting the top 25 collaborators of Ashleigh R. Tuite. A scholar is included among the top collaborators of Ashleigh R. Tuite based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashleigh R. Tuite. Ashleigh R. Tuite is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fisman, David N., et al.. (2024). Case-cohort design as an efficient approach to evaluating COVID-19 vaccine effectiveness, waning, heterologous immune effect and optimal dosing interval. Vaccine. 42(25). 126134–126134.

Drolet, Mélanie, Jean‐François Laprise, Chantal Sauvageau, et al.. (2024). Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis. Canadian Medical Association Journal. 196(33). E1136–E1143.

Lin, Yi-Chan, David H. Evans, Kento T. Abe, et al.. (2023). Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021. Microbiology Spectrum. 11(4). e0525622–e0525622.

Tunis, Matthew, Beate Sander, Murray Krahn, et al.. (2023). Guidelines for the Economic Evaluation of Vaccination Programs in Canada. SSRN Electronic Journal. 3 indexed citations

Fisman, David N. & Ashleigh R. Tuite. (2022). Age-Specific Changes in Virulence Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern. Clinical Infectious Diseases. 75(1). e69–e75. 11 indexed citations

Tuite, Ashleigh R., et al.. (2022). Severity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Pregnancy in Ontario: A Matched Cohort Analysis. Clinical Infectious Diseases. 76(3). e200–e206. 4 indexed citations

Tuite, Ashleigh R., et al.. (2022). Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2. Clinical Infectious Diseases. 76(3). e409–e415. 11 indexed citations

Harish, Vinyas, Lori Diemert, Ashleigh R. Tuite, et al.. (2022). Governing partnerships with technology companies as part of the COVID-19 response in Canada: A qualitative case study. SHILAP Revista de lepidopterología. 1(12). e0000164–e0000164. 5 indexed citations

Lin, Yi-Chan, David H. Evans, Queenie Hu, et al.. (2022). Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses. Microbiology Spectrum. 10(5). e0281122–e0281122. 7 indexed citations

10.

Brankston, Gabrielle, Eric Merkley, David N. Fisman, et al.. (2021). Quantifying contact patterns in response to COVID-19 public health measures in Canada. BMC Public Health. 21(1). 2040–2040. 20 indexed citations

11.

Saeed, Sahar, Sheila F. O’Brien, Kento T. Abe, et al.. (2021). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard. PLoS ONE. 16(9). e0257743–e0257743. 12 indexed citations

12.

Berry, Isha, Shelby L. Sturrock, James E. Wright, et al.. (2021). A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada. Scientific Data. 8(1). 173–173. 18 indexed citations

13.

Brankston, Gabrielle, Eric Merkley, David N. Fisman, et al.. (2021). Socio-demographic disparities in knowledge, practices, and ability to comply with COVID-19 public health measures in Canada. Canadian Journal of Public Health. 112(3). 363–375. 42 indexed citations

14.

Tuite, Ashleigh R., Deepit Bhatia, Rahim Moineddin, et al.. (2020). Global trends in air travel: implications for connectivity and resilience to infectious disease threats. Journal of Travel Medicine. 27(4). 34 indexed citations

15.

Huber, Carmen, Alexander Watts, Jean Hai Ein Yong, et al.. (2020). Modelling airport catchment areas to anticipate the spread of infectious diseases across land and air travel. Spatial and Spatio-temporal Epidemiology. 36. 100380–100380. 10 indexed citations

16.

Weiss, Kevin M., Jeb Jones, Thomas L. Gift, et al.. (2019). Optimizing Coverage vs Frequency for Sexually Transmitted Infection Screening of Men Who Have Sex With Men. Open Forum Infectious Diseases. 6(10). ofz405–ofz405. 14 indexed citations

17.

Rönn, Minttu M., Ashleigh R. Tuite, Nicolas A. Menzies, et al.. (2018). The Impact of Screening and Partner Notification on Chlamydia Prevalence and Numbers of Infections Averted in the United States, 2000–2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model. American Journal of Epidemiology. 188(3). 545–554. 17 indexed citations

18.

Kwong, Jeffrey C., Deepit Bhatia, Rahim Moineddin, et al.. (2017). The Effect of Changes in Cervical Cancer Screening Guidelines on Chlamydia Testing. The Annals of Family Medicine. 15(4). 329–334. 13 indexed citations

19.

Tuite, Ashleigh R.. (2016). Can Enhanced Screening of Men with a History of Prior Syphilis Infection Stem the Epidemic in Men Who Have Sex with Men? a Mathematical Modeling Study. 1 indexed citations

20.

Arino, Julien, Chris T. Bauch, Fred Brauer, et al.. (2011). Pandemic influenza: Modelling and public health perspectives. Mathematical Biosciences & Engineering. 8(1). 1–20. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact